Tag: major cardiovascular events

FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction in adults with obesity

The U.S. Food and Drug Administration (FDA) has recently granted an additional indication for Novo Nordisk's Wegovy, a milestone in medical advancements aimed at combating ... Read More